Oncoinvent ASA: Second half 2025 results
Prnewswire·2026-02-26 06:26
[https://mb.cision.com/Public/15728/4313178/b79ae34c93871998.pdf]20260226 Oncoinvent 2H 2025 report[https://mb.cision.com/Public/15728/4313178/b034e378391f908e.pdf]20260226 Oncoinvent 2H25 presentationSOURCE Oncoinvent ASA## 21%[more press release views with Request a Demo]---- -- Oncoinvent ASA: Second half 2025 results [Accessibility Statement] Skip NavigationOSLO, Norway, Feb. 26, 2026 /PRNewswire/ -- Oncoinvent (OSE: ONCIN), a biotech company developing a receptor-independent alpha radiopharmaceutical t ...